Greenway Greenhouse CannabisGWAYF +0.94%24 Gross Margin % is 29.01% as of Dec. 2025, which is 81% above its 10-year median of 15.99. GuruFocus rates GWAYF with a GF Score™ of 24/100 and a GF Value™ of $0.28 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 935 Drug Manufacturers companies, Greenway Greenhouse Cannabis ranks worse than 67.91% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Greenway Greenhouse Cannabis had a gross margin of 29.01% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Greenway Greenhouse Cannabis Gross Margin % Related Terms
Greenway Greenhouse Cannabis Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Greenway Greenhouse Cannabis's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenway Greenhouse Cannabis Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Greenway Greenhouse Cannabis's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Greenway Greenhouse Cannabis's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Greenway Greenhouse Cannabis (GWAYF) has a Gross Margin % of 29.01% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Greenway Greenhouse Cannabis and its competitors. This is 81% above median its historical median of 15.99. According to the industry distribution chart, Greenway Greenhouse Cannabis ranks #635 out of 935 companies in the Drug Manufacturers industry, placing it in the top 67.9%.
Is Greenway Greenhouse Cannabis' Gross Margin % too high?
Greenway Greenhouse Cannabis' current Gross Margin % of 29.01% is 81% above median its 10-year median of 15.99. The Drug Manufacturers industry median Gross Margin % is 48.54. Greenway Greenhouse Cannabis' value of 29.01% is 40.2% below this industry median. Based on the distribution chart, Greenway Greenhouse Cannabis ranks #635 out of 935 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Greenway Greenhouse Cannabis has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Greenway Greenhouse Cannabis' Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Greenway Greenhouse Cannabis ranks #635 out of 935 companies for Gross Margin %. This places Greenway Greenhouse Cannabis in the lower half of its industry. The industry median Gross Margin % is 48.54. Greenway Greenhouse Cannabis' value of 29.01% is 40.2% below this benchmark. While the company's 10-year median is 15.99 vs. the industry median of 48.54, Greenway Greenhouse Cannabis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Greenway Greenhouse Cannabis's current Gross Margin % of 29.01% is 40.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Greenway Greenhouse Cannabis and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greenway Greenhouse Cannabis's current Gross Margin % is 29.01%, which is 81% above median its own 10-year median of 15.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenway Greenhouse Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis (GWAYF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.28, compared to a current price of $0.10 — trading 63.6% below its estimated fair value. The current Gross Margin % is 29.01%, which is 81% above median its 10-year median of 15.99 and 40.2% below the Drug Manufacturers industry median of 48.54. Greenway Greenhouse Cannabis' overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Greenway Greenhouse Cannabis (GWAYF), the current Gross Margin % is 29.01% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Greenway Greenhouse Cannabis (GWAYF) Overvalued in 2026?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis stock appears to be undervalued.
The current stock price of $0.10 is trading 63.6% below its estimated GF Value™ of $0.28.
GuruFocus considers Greenway Greenhouse Cannabis to be Possible Value Trap.
Key valuation signals for GWAYF:
Gross Margin %: 29.01% (81% above median its 10-year median of 15.99)
GF Value™: $0.28 vs. price of $0.10 (63.6% below fair value)
Industry Position: 40.2% below the Drug Manufacturers median (#635 of 935)
No single metric tells the full story. See the GWAYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.
24GF Score
Get the complete analysis for GWAYF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GWAYF has been successfully added to your 
